home / stock / apyx / apyx news


APYX News and Press, Apyx Medical Corporation From 08/30/21

Stock Information

Company Name: Apyx Medical Corporation
Stock Symbol: APYX
Market: NASDAQ
Website: apyxmedical.com

Menu

APYX APYX Quote APYX Short APYX News APYX Articles APYX Message Board
Get APYX Alerts

News, Short Squeeze, Breakout and More Instantly...

APYX -  Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company's Board of Directors

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

APYX - Apyx Medical shares surge on Advanced Energy business driven Q2 beat

Apyx Medical shares surge (APYX +16.6%) after the company reported second-quarter results that beat Wall Street estimates, helped by the strength in its Advanced Energy business. Advanced Energy revenue increased 248% YOY to $10M in the second-quarter. "...we saw impressive growth in glo...

APYX - Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2021 Results - Earnings Call Transcript

Apyx Medical Corporation (APYX) Q2 2021 Results Earnings Conference Call August 12, 2021, 08:00 AM ET Company Participants Charlie Goodwin - President & Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Russell Cleveland - ...

APYX - NanoVibronix, Apyx Medical leads healthcare gainers; MedAvail, LifeStance Health among major losers

Gainers: NanoVibronix (NASDAQ:NAOV) +27%, Apyx Medical (NASDAQ:APYX) +20%, Xenetic Biosciences (NASDAQ:XBIO) +19%, Doximity (NYSE:DOCS) +15%, OncoCyte (NASDAQ:OCX) +14%. Losers: MedAvail (NASDAQ:MDVL) -51%, LifeStance Health (NASDAQ:LFST) -49%...

APYX - Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

Advanced Energy Sales increased 248% year-over-year in Q2 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosm...

APYX - Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

APYX - Digital Health Could Help Fix the Broken U.S. Healthcare Market

The multi-trillion-dollar U.S. healthcare market is broken. At the moment, the system is fragmented, meaning there exists a lack of coordination that often results in an inefficient allocation of resources. “Fragmentation adversely impacts quality, cost, and outcomes. Eliminating was...

APYX - Some of the Top Ways to Invest in a Potential $379 Billion Digital Health Market

With greater demand for digital health, the U.S. government is investing $80 million to create a new public health informatic and technology program. In fact, according to Forbes, “Over the past decade, the idea of digital health has transformed from simple patient-portals and rudime...

APYX - Digital Health Monitoring Creating a $245 Billion Investment Opportunity

These days, millions are are turning to digital health solutions, some of which can reportedly help manage diabetes, improve sleep, monitor heart health, encourage weight loss and track whether patients are sticking to regimens, as noted by The Wall Street Journal. In fact, after the health...

APYX - Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Previous 10 Next 10